iShares
ESIH.L
IE00BMW42181
iShares MSCI Europe Health Care Sector UCITS ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
21.31
Weighted Fwd P/E
17.55
Avg P/FCF
21.81
Avg FCF Yield
4.32%
Avg EV / EBITDA
13.32
Avg EV / Revenue
8.98
Avg Price-to-Book (P/B)
97.56
Avg Price-to-Sales (P/S)
9.55
Avg Dividend Yield
0.03%
P/E Compression (Trailing vs Fwd)
-17.63%
Avg Debt-to-Equity (D/E)
74.05%
<50% (21.65%) 50-150% (77.42%) >150% (0.68%) Unreported (0.24%)

Profitability Analysis

38 Holdings Count
Profitable 99.62%
Profitable 99.62%
37 Holdings Count (97.37%)
Unprofitable 0.38%
1 Holdings Count (2.63%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
58.6%
Top 10
76.0%
Top 25
94.7%
50% Threshold
Top 4
The top 10 holdings account for 76% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

11 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (10.7%+)
High (27.9%+)
Top (38.6%+)

Country Breakdown

Max: 42.94%
CH CH CH
42.94%
GB GB GB
21.66%
DK DK DK
9.66%
FR FR FR
9.43%
DE DE DE
6.99%
NL NL NL
5.07%
BE BE BE
1.91%
FI FI FI
0.54%
LU LU LU
0.52%
SE SE SE
0.47%
IT IT IT
0.34%

Sector Distribution

1 Sector
Healthcare
99.53%

Industry Distribution

7 Industries
Drug Manufacturers - General
68.40%
Drug Manufacturers - Specialty & Generic
8.37%
Biotechnology
6.86%
Medical Instruments & Supplies
6.79%
Diagnostics & Research
3.91%
Medical Devices
3.50%
Medical Care Facilities
1.70%

Market Cap Distribution

38 Holdings Count
Mega Cap (> 200B)
(4) 46.02%
Large Cap (10B - 200B)
(29) 52.04%
Mid Cap (2B - 10B)
(5) 1.48%
ende